Suppression of IFN-g and IL-2 production in transgenic mice expressing the core protein of hepatitis C virus (HCV)

被引：0
|
作者：
Joo, M [1 ]
Chianese-Bullock, KA [1 ]
Nguyen, T [1 ]
Hahn, YS [1 ]
机构：
[1] Univ Virginia, Dept Pathol, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA
来源：
FASEB JOURNAL | 2000年 / 14卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1038 / A1038
页数：1
相关论文
共 50 条
  • [1] Hepatitis C virus core and E2 protein expression in transgenic mice
    Pasquinelli, C
    Shoenberger, JM
    Chung, J
    Chang, KM
    Guidotti, LG
    Selby, M
    Berger, K
    Lesniewski, R
    Houghton, M
    Chisari, FV
    HEPATOLOGY, 1997, 25 (03) : 719 - 727
  • [2] Activation of mitogen-activated protein kinases in the liver of transgenic mice expressing hepatitis C virus core protein.
    Tsutsumi, T
    Suzuki, T
    Moriya, K
    Shintani, Y
    Fujie, H
    Miyoshi, H
    Koike, K
    Miyamura, T
    HEPATOLOGY, 2002, 36 (04) : 269A - 269A
  • [3] Increased liver pathology in hepatitis C virus transgenic mice expressing the hepatitis B virus X protein
    Keasler, VV
    Lerat, H
    Madden, CR
    Finegold, MJ
    McGarvey, MJ
    Mohammed, EMA
    Forbes, SJ
    Lemon, SM
    Hadsell, DL
    Grona, SJ
    Hollinger, FB
    Slagle, BL
    VIROLOGY, 2006, 347 (02) : 466 - 475
  • [4] Hepatitis C virus core protein induces hepatic steatosis in transgenic mice
    Moriya, K
    Yotsuyanagi, H
    Shintani, Y
    Fujie, H
    Ishibashi, K
    Matsuura, Y
    Miyamura, T
    Koike, K
    JOURNAL OF GENERAL VIROLOGY, 1997, 78 : 1527 - 1531
  • [5] The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
    Kyoji Moriya
    Hajime Fujie
    Yoshizumi Shintani
    Hiroshi Yotsuyanagi
    Takeya Tsutsumi
    Kotaro Ishibashi
    Yoshiharu Matsuura
    Satoshi Kimura
    Tatsuo Miyamura
    Kazuhiko Koike
    Nature Medicine, 1998, 4 : 1065 - 1067
  • [6] The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
    Moriya, K
    Fujie, H
    Shintani, Y
    Yotsuyanagi, H
    Tsutsumi, T
    Ishibashi, K
    Matsuura, Y
    Kimura, S
    Miyamura, T
    Koike, K
    NATURE MEDICINE, 1998, 4 (09) : 1065 - 1067
  • [7] Genetic immunization breaks tolerance in hepatitis C virus (HCV) core transgenic mice.
    Encke, J
    Geissler, M
    de la Monte, S
    Schmidt, EV
    Wands, JR
    HEPATOLOGY, 1998, 28 (04) : 466A - 466A
  • [8] Production of transgenic mice expressing human protein C
    Min, Kwan-Sik
    Nanjidsuren, Tsevelmaa
    Park, Chae-Won
    Yun, Sung-Jo
    FASEB JOURNAL, 2013, 27
  • [9] Lethality in mice infected with recombinant vaccinia virus expressing hepatitis C virus core protein
    Hong Zhang the ISIS Pharmaceuticals
    Hepatobiliary & Pancreatic Diseases International, 2003, (03) : 374 - 382
  • [10] Clinical phase I trial:: therapy for feline fibrosarcoma with recombinant adenovirus vectors expressing human IL-2 and feline IFN-g
    Brill, T
    Homann, H
    Wieland, S
    Ludwig, J
    Köstlin, R
    Gansbacher, B
    Hirschberger, J
    CANCER GENE THERAPY, 2001, 8 (11) : 921 - 921
12345